Global Gynecological Surgical Devices Market to Reach $8.4 Billion by 2027
Amid the COVID-19 crisis, the global market for Gynecological Surgical Devices estimated at US$7.4 Billion in the year 2020, is projected to reach a revised size of US$8.4 Billion by 2027, growing at a CAGR of 1.7% over the analysis period 2020-2027. Female Sterilization & Contraceptive Devices, one of the segments analyzed in the report, is projected to record a 2.2% CAGR and reach US$4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Endoscopy Devices segment is readjusted to a revised 1.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $2 Billion, While China is Forecast to Grow at 3.4% CAGR
The Gynecological Surgical Devices market in the U.S. is estimated at US$2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 3.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.2% and 1.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 0.6% CAGR.
Fluid management System Segment to Record 1% CAGR
In the global Fluid management System segment, USA, Canada, Japan, China and Europe will drive the 0.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1 Billion in the year 2020 will reach a projected size of US$1.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.1 Billion by the year 2027, while Latin America will expand at a 1.6% CAGR through the analysis period. We bring years of research experience to this 16th edition of our report. The 306-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Competitors identified in this market include, among others,
- B. Braun Melsungen AG
- BARD, A Becton, Dickinson Company
- Boston Scientific Corporation
- Coloplast A/S
- ConMed Corporation
- CooperSurgical, Inc.
- Ethicon US LLC
- Integra LifeSciences Holdings Corporation
- Intuitive Surgical, Inc.
- Johnson & Johnson
- KARL STORZ Endoscopy-America, Inc.
- Medtronic, Inc.
- Olympus Corporation
- PhotoMedex, Inc.
- ProSurg, Inc.
- Richard Wolf GmbH
- Smith & Nephew PLC
- Stryker Corporation
- Utah Medical Products, Inc.